Similar Items: Enhancement of immune checkpoint inhibitor efficacy by DHX58+ SELL+ T cells in advanced gastric cancer
- Second generation tyrosine kinase inhibitors for the treatment of metastatic non-small-cell lung cancer
- Integrative genomic analysis reveals DHX58 as a key player in gastric cancer
- PEGylation strategies for enhanced nanoparticle delivery to tumor‐associated immune cells
- Targeting delayed healing tissues: immune reprogramming of adaptive immune cells by biomaterials
- Cutting‐edge advances in bicyclic peptide‐based radiotracers for cancer imaging and theranostics
- Immune escape mechanisms revealed by multifunctional nanoprobes targeting PD‐L1 in hepatic cancer progression